Skip to main content
. 2020 Oct 20;21(20):7767. doi: 10.3390/ijms21207767

Table A1.

Patient #1 laboratory findings.

Pt#1 ESR mm/h IS CRP mg/L WBC/μL HB g/dL PLT/μL IgG mg/dL IgA mg/dL
Before JAKinhibs 9 83 9.9 3350 12.7 107,000 855 124
After JAKinhibs 13 62 0.3 2610 12.2 146,000 459 69
Last FUP 12 22.4 5.5 1680 14.0 130,000 702 61